1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Companion Diagnostics In Personalized Medicine and Therapy Industry 2015 Market Research Report


The Global Companion Diagnostics In Personalized Medicine And Therapy Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Companion Diagnostics In Personalized Medicine And Therapy industry.

The report provides a basic overview of the industry including definitions and classifications. The Companion Diagnostics In Personalized Medicine And Therapy market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 139 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Companion Diagnostics In Personalized Medicine and Therapy Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Basic Information of Companion Diagnostics In Personalized Medicine And Therapy
1.1.1 Definition of Companion Diagnostics In Personalized Medicine And Therapy
1.1.2 Classifications of Companion Diagnostics In Personalized Medicine And Therapy
1.1.3 Applications of Companion Diagnostics In Personalized Medicine And Therapy
1.1.4 Characteristics of Companion Diagnostics In Personalized Medicine And Therapy
1.2 Development Overview of Companion Diagnostics In Personalized Medicine And Therapy
1.3 Enter Barriers Analysis of Companion Diagnostics In Personalized Medicine And Therapy

2 Companion Diagnostics In Personalized Medicine And Therapy International and China Market Analysis
2.1 Companion Diagnostics In Personalized Medicine And Therapy Industry International Market Analysis
2.1.1 Companion Diagnostics In Personalized Medicine And Therapy International Market Development History
2.1.2 Companion Diagnostics In Personalized Medicine And Therapy Competitive Landscape Analysis
2.1.3 Companion Diagnostics In Personalized Medicine And Therapy International Main Countries Development Status
2.1.4 Companion Diagnostics In Personalized Medicine And Therapy International Market Development Trend
2.2 Companion Diagnostics In Personalized Medicine And Therapy Industry China Market Analysis
2.2.1 Companion Diagnostics In Personalized Medicine And Therapy China Market Development History
2.2.2 Companion Diagnostics In Personalized Medicine And Therapy Competitive Landscape Analysis
2.2.3 Companion Diagnostics In Personalized Medicine And Therapy China Main Regions Development Status
2.2.4 Companion Diagnostics In Personalized Medicine And Therapy China Market Development Trend
2.3 Companion Diagnostics In Personalized Medicine And Therapy International and China Market Comparison Analysis

3 Environment Analysis of Companion Diagnostics In Personalized Medicine And Therapy
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Companion Diagnostics In Personalized Medicine And Therapy
3.4 News Analysis of Companion Diagnostics In Personalized Medicine And Therapy

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Companion Diagnostics In Personalized Medicine And Therapy by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy by Classifications 2010-2015
4.3 Companion Diagnostics In Personalized Medicine And Therapy Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Companion Diagnostics In Personalized Medicine And Therapy by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy
5.5 2010-2015 China Revenue and Revenue Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy

6 Analysis of Companion Diagnostics In Personalized Medicine And Therapy Revenue Market Status 2010-2015
6.1 Revenue of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015
6.2 Revenue Market Share Analysis of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015
6.3 Revenue Overview of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015
6.4 Gross Margin of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015

7 Analysis of Companion Diagnostics In Personalized Medicine And Therapy Industry Key Manufacturers
7.1 20/20 GeneSystems
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 20/20 GeneSystems SWOT Analysis

7.2 Abbott Molecular
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Abbott Molecular SWOT Analysis

7.3 Affymetrix
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Affymetrix SWOT Analysis

7.4 Agendia
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Agendia SWOT Analysis

7.5 Agilent
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Agilent SWOT Analysis

7.6 Almac Group
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Almac Group SWOT Analysis

7.7 Applied Biosystems
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 Applied Biosystems SWOT Analysis

7.8 Asuragen
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 Asuragen SWOT Analysis

7.9 Aureon
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Aureon SWOT Analysis

7.10 Becton Dickinson
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Becton Dickinson SWOT Analysis

7.11 Biodesix
7.11.1 Company Profile
7.11.2 Revenue and Gross Margin
7.11.3 Biodesix SWOT Analysis

7.12 Panacea Pharmaceuticals
7.12.1 Company Profile
7.12.2 Revenue and Gross Margin
7.12.3 Panacea Pharmaceuticals SWOT Analysis

7.13 BioModa
7.13.1 Company Profile
7.13.2 Revenue and Gross Margin
7.13.3 BioModa SWOT Analysis

7.14 Byk Gulden
7.14.1 Company Profile
7.14.2 Revenue and Gross Margin
7.14.3 Byk Gulden SWOT Analysis

7.15 Caprion Proteomics
7.15.1 Company Profile
7.15.2 Revenue and Gross Margin
7.15.3 Caprion Proteomics SWOT Analysis

7.16 Celera Diagnostics
7.16.1 Company Profile
7.16.2 Revenue and Gross Margin
7.16.3 Celera Diagnostics SWOT Analysis

7.17 Cepheid
7.17.1 Company Profile
7.17.2 Revenue and Gross Margin
7.17.3 Cepheid SWOT Analysis

7.18 Clarient
7.18.1 Company Profile
7.18.2 Revenue and Gross Margin
7.18.3 Clarient SWOT Analysis

7.19 Biomira
7.19.1 Company Profile
7.19.2 Revenue and Gross Margin
7.19.3 Biomira SWOT Analysis

7.20 TrimGen
7.20.1 Company Profile
7.20.2 Revenue and Gross Margin
7.20.3 TrimGen SWOT Analysis

7.21 Transgenomic
7.21.1 Company Profile
7.21.2 Revenue and Gross Margin
7.21.3 Transgenomic SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Companion Diagnostics In Personalized Medicine And Therapy
8.2 Gross Margin Analysis of Companion Diagnostics In Personalized Medicine And Therapy

9 Marketing Trader or Distributor Analysis of Companion Diagnostics In Personalized Medicine And Therapy
9.1 Marketing Channels Status of Companion Diagnostics In Personalized Medicine And Therapy
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Companion Diagnostics In Personalized Medicine And Therapy Industry 2016-2021
10.1 Revenue Overview of Companion Diagnostics In Personalized Medicine And Therapy 2016-2021
10.2 Sales Price Overview of Companion Diagnostics In Personalized Medicine And Therapy 2016-2021

11 Industry Chain Suppliers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
11.1 Equipment Suppliers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
11.2 Major Suppliers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
11.3 Key Consumers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
11.4 Supply Chain Relationship Analysis of Companion Diagnostics In Personalized Medicine And Therapy

12 New Project Investment Feasibility Analysis of Companion Diagnostics In Personalized Medicine And Therapy
12.1 New Project SWOT Analysis of Companion Diagnostics In Personalized Medicine And Therapy
12.2 New Project Investment Feasibility Analysis of Companion Diagnostics In Personalized Medicine And Therapy

13 Conclusion of the Global Companion Diagnostics In Personalized Medicine And Therapy Industry 2015 Market Research Report



List of Tables and Figures
Table Classifications of Companion Diagnostics In Personalized Medicine And Therapy
Table Applications of Companion Diagnostics In Personalized Medicine And Therapy
Table Policy of Companion Diagnostics In Personalized Medicine And Therapy
Table Industry News List of Companion Diagnostics In Personalized Medicine And Therapy
Table Global Revenue of Companion Diagnostics In Personalized Medicine And Therapy by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Classifications 2010-2015
Figure Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Classifications in 2010
Figure Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Companion Diagnostics In Personalized Medicine And Therapy Revenue by Classifications
Table Europe Companion Diagnostics In Personalized Medicine And Therapy Revenue by Classifications
Table Japan Companion Diagnostics In Personalized Medicine And Therapy Revenue by Classifications
Table China Companion Diagnostics In Personalized Medicine And Therapy Revenue by Classifications
Table Global Revenue of Companion Diagnostics In Personalized Medicine And Therapy by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Regions 2010-2015
Figure Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Regions in 2010
Figure Global Revenue Market Share of Companion Diagnostics In Personalized Medicine And Therapy by Regions in 2015
Table USA Companion Diagnostics In Personalized Medicine And Therapy Revenue by Applications
Figure USA Companion Diagnostics In Personalized Medicine And Therapy Revenue and Revenue Growth Rate
Table Europe Companion Diagnostics In Personalized Medicine And Therapy Revenue by Applications
Figure Europe Companion Diagnostics In Personalized Medicine And Therapy Revenue and Revenue Growth Rate
Table Japan Companion Diagnostics In Personalized Medicine And Therapy Revenue by Applications
Figure Japan Companion Diagnostics In Personalized Medicine And Therapy Revenue and Revenue Growth Rate
Table China Companion Diagnostics In Personalized Medicine And Therapy Revenue by Applications
Figure China Companion Diagnostics In Personalized Medicine And Therapy Revenue and Revenue Growth Rate
Table Global and China Major Players Companion Diagnostics In Personalized Medicine And Therapy Revenue of 2010-2015 (M USD)
Table Global and China Major Players Companion Diagnostics In Personalized Medicine And Therapy Revenue Market Share of 2010-2015
Table China Major Players Companion Diagnostics In Personalized Medicine And Therapy Revenue of 2010-2015 (M USD)
Table China Major Players Companion Diagnostics In Personalized Medicine And Therapy Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Companion Diagnostics In Personalized Medicine And Therapy Players in 2010
Figure Global Revenue Market Share of Major Companion Diagnostics In Personalized Medicine And Therapy Players in 2015
Figure China Revenue Market Share Major Companion Diagnostics In Personalized Medicine And Therapy Players in 2010
Figure China Revenue Market Share Major Companion Diagnostics In Personalized Medicine And Therapy Players in 2015
Figure Global Revenue and Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015
Figure China Revenue and Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy 2010-2015
Figure 2010-2015 Global and China Companion Diagnostics In Personalized Medicine And Therapy Revenue Comparison
Table Cost of Global Companion Diagnostics In Personalized Medicine And Therapy Major Players 2010-2015 (M USD)
Table Gross of Global Companion Diagnostics In Personalized Medicine And Therapy Major Players 2010-2015 (M USD)
Table Gross Margin of Global Companion Diagnostics In Personalized Medicine And Therapy Major Players 2010-2015
Figure Gross Margin of Global Companion Diagnostics In Personalized Medicine And Therapy Major Players in 2014
Table Company Profile List of 20/20 GeneSystems
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of 20/20 GeneSystems 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of 20/20 GeneSystems 2010-2015
Table SWOT Analysis of 20/20 GeneSystems 2010-2015
Table Company Profile List of Abbott Molecular
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abbott Molecular 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Abbott Molecular 2010-2015
Table SWOT Analysis of Abbott Molecular 2010-2015
Table Company Profile List of Affymetrix
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Affymetrix 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Affymetrix 2010-2015
Table SWOT Analysis of Affymetrix 2010-2015
Table Company Profile List of Agendia
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agendia 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Agendia 2010-2015
Table SWOT Analysis of Agendia 2010-2015
Table Company Profile List of Agilent
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agilent 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Agilent 2010-2015
Table SWOT Analysis of Agilent 2010-2015
Table Company Profile List of Almac Group
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Almac Group 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Almac Group 2010-2015
Table SWOT Analysis of Almac Group 2010-2015
Table Company Profile List of Applied Biosystems
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Applied Biosystems 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Applied Biosystems 2010-2015
Table SWOT Analysis of Applied Biosystems 2010-2015
Table Company Profile List of Asuragen
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Asuragen 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Asuragen 2010-2015
Table SWOT Analysis of Asuragen 2010-2015
Table Company Profile List of Aureon
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Aureon 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Aureon 2010-2015
Table SWOT Analysis of Aureon 2010-2015
Table Company Profile List of Becton Dickinson
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Becton Dickinson 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Becton Dickinson 2010-2015
Table SWOT Analysis of Becton Dickinson 2010-2015
Table Company Profile List of Biodesix
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biodesix 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Biodesix 2010-2015
Table SWOT Analysis of Biodesix 2010-2015
Table Company Profile List of Panacea Pharmaceuticals
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Panacea Pharmaceuticals 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Panacea Pharmaceuticals 2010-2015
Table SWOT Analysis of Panacea Pharmaceuticals 2010-2015
Table Company Profile List of BioModa
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of BioModa 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of BioModa 2010-2015
Table SWOT Analysis of BioModa 2010-2015
Table Company Profile List of Byk Gulden
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Byk Gulden 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Byk Gulden 2010-2015
Table SWOT Analysis of Byk Gulden 2010-2015
Table Company Profile List of Caprion Proteomics
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Caprion Proteomics 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Caprion Proteomics 2010-2015
Table SWOT Analysis of Caprion Proteomics 2010-2015
Table Company Profile List of Celera Diagnostics
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Celera Diagnostics 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Celera Diagnostics 2010-2015
Table SWOT Analysis of Celera Diagnostics 2010-2015
Table Company Profile List of Cepheid
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Cepheid 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Cepheid 2010-2015
Table SWOT Analysis of Cepheid 2010-2015
Table Company Profile List of Clarient
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Clarient 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Clarient 2010-2015
Table SWOT Analysis of Clarient 2010-2015
Table Company Profile List of Biomira
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biomira 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Biomira 2010-2015
Table SWOT Analysis of Biomira 2010-2015
Table Company Profile List of TrimGen
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of TrimGen 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of TrimGen 2010-2015
Table SWOT Analysis of TrimGen 2010-2015
Table Company Profile List of Transgenomic
Table Companion Diagnostics In Personalized Medicine And Therapy Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Transgenomic 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Revenue and Growth Rate of Transgenomic 2010-2015
Table SWOT Analysis of Transgenomic 2010-2015
Figure Companion Diagnostics In Personalized Medicine And Therapy Manufactor Profit Model
Figure Marketing Channels Status of Companion Diagnostics In Personalized Medicine And Therapy
Figure Global Revenue and Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy 2016-2021
Figure China Revenue and Growth Rate of Companion Diagnostics In Personalized Medicine And Therapy 2016-2021
Figure Global and China Companion Diagnostics In Personalized Medicine And Therapy Revenue Comparison 2016-2021
Table Equipment Suppliers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
Table Major Suppliers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
Table Key Consumers of Companion Diagnostics In Personalized Medicine And Therapy with Contact Information
Figure Supply Chain Relationship Analysis of Companion Diagnostics In Personalized Medicine And Therapy
Table New Project SWOT Analysis of Companion Diagnostics In Personalized Medicine And Therapy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.